Literature DB >> 23531927

An 8-year follow-up of a patient with acute myocardial infarction complicated with ventricular rupture and cerebral thrombosis treated conservatively: a cohort study.

Xue Li1, Lianyou Zhao, Qiangsun Zheng.   

Abstract

Cardiac rupture is a complication of myocardial infarction (MI) with extremely high mortality. Poor prognosis is usually predicted in conservatively treated patients. The treatment for cardiac rupture and thrombosis is in conflict. We reported an MI case of cardiac rupture and cerebral thrombosis using a conservative method. This case indicated that (1) It is noteworthy that patients suffering from the subacute form of rupture may remain haemodynamically stable. This type of patients may benefit from a conservative treatment without anticoagulation or antiplatelet at the onset of cardiac rupture. (2) Thirty days following cardiac rupture, it is safe to use warfarin anticoagulation for cerebral thrombosis treatment. The patient suffered from acute MI, cardiac rupture and subsequently cerebral thrombosis. We treated this patient in a conservative manner and the patient remained alive for 8 years. This case suggested that it may be safe to use warfarin anticoagulation treatment for cerebral thrombosis 30 days following cardiac rupture.

Entities:  

Mesh:

Year:  2013        PMID: 23531927      PMCID: PMC3618746          DOI: 10.1136/bcr-2012-007878

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Left ventricular free wall rupture: clinical presentation and management.

Authors:  J Figueras; J Cortadellas; J Soler-Soler
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

2.  Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction.

Authors:  Raúl Moreno; José López-Sendón; Eulogio García; Leopoldo Pérez de Isla; Esteban López de Sá; Ana Ortega; Mar Moreno; Rafael Rubio; Javier Soriano; Manuel Abeytua; Miguel-Angel García-Fernández
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Clinical and pathologic features of postinfarction cardiac rupture.

Authors:  A J Lewis; H B Burchell; J L Titus
Journal:  Am J Cardiol       Date:  1969-01       Impact factor: 2.778

4.  Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction.

Authors:  Yang Liu; Xiao-Ming Gao; Lu Fang; Nicole L Jennings; Yidan Su; Xu Q; Andre L Samson; Helen Kiriazis; Xin-Feng Wang; Leonard Shan; Sharelle A Sturgeon; Robert L Medcalf; Shaun P Jackson; Anthony M Dart; Xiao-Jun Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

5.  Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators.

Authors:  S D Gertz; A H Kragel; J M Kalan; E Braunwald; W C Roberts
Journal:  Am J Cardiol       Date:  1990-10-15       Impact factor: 2.778

6.  Subacute rupture of the left ventricular free wall after acute myocardial infarction. Three cases of long-term survival without emergency surgical repair.

Authors:  A Blinc; M Noc; B Pohar; N Cernic; M Horvat
Journal:  Chest       Date:  1996-02       Impact factor: 9.410

7.  Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations.

Authors:  P B Oliva; S C Hammill; W D Edwards
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

8.  Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of coronary care units.

Authors:  S G Reddy; W C Roberts
Journal:  Am J Cardiol       Date:  1989-04-15       Impact factor: 2.778

9.  True and false aneurysms of the left ventricle following myocardial infarction.

Authors:  R H Martin; C H Almond; S Saab; L E Watson
Journal:  Am J Med       Date:  1977-03       Impact factor: 4.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.